QQ客服 官方微博 反馈留言

	Randomized, double-blind, placebo-controlled, multicenter Phase II study of fruquintinib after two prior chemotherapy regimens in Chinese patients with advanced nonsquamous non-small-cell lung cancer
	Lu, S.; Chang, J.; Liu, X.; Shi, J.; Lu, Y.; Li, W.; Yang, J.-J.; Zhou, J.; Wang, J.; An, T.
刊名	Journal of Clinical Oncology
	2018
卷号	Vol.36 No.12页码:1207-1217
ISSN号	0732-183X
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1820862
专题	四川大学
作者单位	1.m Southwest Hospital, Chongqing, China 2.Beijing Cancer Hospital, Beijing, China 3.l Nantong Tumor Hospital, Nantong, China 4.Hutchison MediPharma Limited, Shanghai, China 5.307 Hospital of Chinese People's Liberation Army, Beijing, China 6.i First Hospital of Jilin University, Changchun, China 7.g Linyi Cancer Hospital, Linyi, China 8.j Guangdong General Hospital, Guangzhou, China 9.Fudan University Shanghai Cancer Center, Shanghai, China 10.f Capital Medical University, Beijing, China
推荐引用方式 GB/T 7714	Lu, S.,Chang, J.,Liu, X.,et al. Randomized, double-blind, placebo-controlled, multicenter Phase II study of fruquintinib after two prior chemotherapy regimens in Chinese patients with advanced nonsquamous non-small-cell lung cancer[J]. Journal of Clinical Oncology,2018,Vol.36 No.12:1207-1217.
APA	Lu, S..,Chang, J..,Liu, X..,Shi, J..,Lu, Y..,...&Su, W..(2018).Randomized, double-blind, placebo-controlled, multicenter Phase II study of fruquintinib after two prior chemotherapy regimens in Chinese patients with advanced nonsquamous non-small-cell lung cancer.Journal of Clinical Oncology,Vol.36 No.12,1207-1217.
MLA	Lu, S.,et al."Randomized, double-blind, placebo-controlled, multicenter Phase II study of fruquintinib after two prior chemotherapy regimens in Chinese patients with advanced nonsquamous non-small-cell lung cancer".Journal of Clinical Oncology Vol.36 No.12(2018):1207-1217.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。